Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immune Checkpoint Inhibitors × Other hematologic neoplasm × Clear all

Sponsor

Cancer Type

Thoracic 4 Head & Neck 2 Genitourinary 2 Other solid neoplasm 1 Dermatologic 1 CNS 1 Breast 1

Interventions

Cyclophosphamide 256 Cytarabine 228 fludarabine phosphate 186 Rituximab 176 fludarabine 156 Methotrexate 122 Whole-Body Irradiation 120 Azacitidine 106 Mycophenolic Acid 100 Busulfan 90 Tacrolimus 88 Filgrastim 84 Etoposide 81 Vincristine 76 Granulocyte Colony-Stimulating Factor 76 Dexamethasone 76 Peripheral Blood Stem Cell Transplantation 70 Melphalan 67 Decitabine 63 Lenalidomide 61 Cyclosporine 61 Clofarabine 60 Daunorubicin 59 Antilymphocyte Serum 58 Imatinib Mesylate 52 Calcium Dobesilate 51 venetoclax 50 ibrutinib 49 Doxorubicin 49 Alemtuzumab 48

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡